Today

Agents

Chat

Arena

Discover

More

App

Palvella Therapeutics target price raised to $243 from $232 - PVLA News | Rallies

Palvella Therapeutics target price raised to $243 from $232

PVLA•2026-11-06

Canaccord Genuity raised its target price for Palvella Therapeutics to $243 from $232.

Related News

UBS raises Celsius Holdings target price to $42 from $38

CELH•2026-11-06

US Foods Holding Corp.: UBS raises target price to $135 from $127

USFD•2026-11-06

Ralph Lauren target price raised to $529 from $521

RL•2026-11-06

NYSE halt, add info LST $6.60

GTN.A•2026-11-06

Nasdaq halts PASG trading after volatility pause at 9:37 a.m.

PASG•2026-11-06